Cosciens Biopharma Inc.
13F holders, Q3 2025 (September 30)2holders −13
0new positions
13sold out
$2.64avg. 13F price*
At the end of Q3 2025, 2 institutions reported holding Cosciens Biopharma Inc. in their 13F filings, down 13 from Q2 2025. 0 opened new positions and 13 sold out. The largest holders were TD Waterhouse Canada Inc. ($10K) and Osaic Holdings, Inc. ($153).
- Company
- Cosciens Biopharma Inc.
- CUSIP
- 22112H101
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 13 | $77K |
All 13F filers, Q2 2025 → Q3 2025: 22,924 shares sold, net −22,924 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| TD Waterhouse Canada Inc. | 0.00% | No change | 3,860 | $10K |
| Osaic Holdings, Inc. | 0.00% | No change | 50 | $153 |
"% of holder's portfolio" is COSCIENS BIOPHARMA INC's weight in each manager's 13F, not the share of Cosciens Biopharma Inc. the manager owns.